We are live on ! Find out more
KRTX

Karuna Therapeutics, Inc. Common Stock
KRTX

Delisted

KRTX was delisted on the 15th of March, 2024.

Back to rankings

2 hedge funds and large institutions have $270K invested in Karuna Therapeutics, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 325 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 328 → 2 (-326)

100% less funds holding in top 10

Funds holding in top 10: 26 → 0 (-26)

100% less capital invested

Capital invested by funds: $12B → $270K (-$12B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 325

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
-326
Holders Change %
-99.39%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
-26
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
325
Calls
$2K
Puts
–
Net Calls
+$2K
Net Calls Change
-$46.5M

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Capital International Investors
Capital International Investors
California
-$1.34B
2
Vanguard Group
Vanguard Group
Pennsylvania
-$1.02B
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$907M
4
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
-$858M
5
BlackRock
BlackRock
New York
-$638M
Name Holding Trade Value Shares
Change 		Change in
Stake
OAM
226
Oxford Asset Management
United Kingdom
– -$674K -2,128 Closed
CCP
227
Clough Capital Partners
Massachusetts
– -$646K -2,040 Closed
FIA
228
FNY Investment Advisers
New York
– -$633K -2,000 Closed
MIM
229
MetLife Investment Management
New Jersey
– -$633K -2,000 Closed
URS
230
Utah Retirement Systems
Utah
– -$633K -2,000 Closed
RJA
231
Raymond James & Associates
Florida
– -$631K -1,993 Closed
VPIM
232
Vanguard Personalized Indexing Management
California
– -$616K -1,946 Closed
Mariner
233
Mariner
Kansas
– -$602K -1,902 Closed
PCM
234
PenderFund Capital Management
British Columbia, Canada
– -$797K -1,900 Closed
HI
235
Handelsinvest Investeringsforvaltning
Denmark
– -$582K -1,839 Closed
Osaic Holdings
236
Osaic Holdings
Arizona
– -$512K -1,618 Closed
SAM
237
Shell Asset Management
Netherlands
– -$444K -1,404 Closed
Squarepoint
238
Squarepoint
New York
– -$420K -1,328 Closed
ATC
239
Argent Trust Co
Tennessee
– -$420K -1,326 Closed
Wealth Enhancement Advisory Services
240
Wealth Enhancement Advisory Services
Minnesota
– -$401K -1,268 Closed
Creative Planning
241
Creative Planning
Kansas
– -$396K -1,251 Closed
LPL Financial
242
LPL Financial
California
– -$383K -1,211 Closed
HT
243
Headlands Technologies
Illinois
– -$374K -1,182 Closed
DC
244
Diametric Capital
Massachusetts
– -$372K -1,174 Closed
JF
245
Jump Financial
Illinois
– -$370K -1,170 Closed
LCM
246
Legato Capital Management
California
– -$354K -1,117 Closed
OIA
247
OneDigital Investment Advisors
Kansas
– -$351K -1,110 Closed
M&T Bank
248
M&T Bank
New York
– -$337K -1,065 Closed
HHGC
249
Hunting Hill Global Capital
New York
– -$329K -1,038 Closed
Cetera Investment Advisers
250
Cetera Investment Advisers
Illinois
– -$328K -1,037 Closed
8 9
10
11 12

KRTX Hedge Fund Activity: Q1 2024 in Review

2 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Karuna Therapeutics, Inc. Common Stock (KRTX) for Q1 2024, worth a combined $270K — down 100% from $12B a quarter earlier.

Sellers outnumbered buyers: 325 funds closed out of KRTX and 0 opened new positions — a net loss of 325 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was Capital International Investors, exiting entirely with an estimated $1.34B sold.

  • 2 institutional investors held Karuna Therapeutics, Inc. Common Stock (KRTX) as of Q1 2024, down from 328 in Q4 2023.
  • Funds reported $270K of Karuna Therapeutics, Inc. Common Stock stock for Q1 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Karuna Therapeutics, Inc. Common Stock positions in Q1 2024 and 325 closed out, a net change of -325 holders.
  • The largest Karuna Therapeutics, Inc. Common Stock seller in Q1 2024 was Capital International Investors, an estimated $1.34B sold.

Based on aggregated 13F filings for Q1 2024.